Please login to the form below

Not currently logged in
Email:
Password:

Europe

This page shows the latest Europe news and features for those working in and with pharma, biotech and healthcare.

Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children

Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children

Around 80, 000 infants and young children in Europe are living with uncontrolled cases of atopic dermatitis, a chronic type 2 inflammatory skin disease.

Latest news

More from news
Approximately 77 fully matching, plus 3,427 partially matching documents found.

Latest Intelligence

  • Life sciences reimagined Life sciences reimagined

    Even though the worst of the recent crisis appears to be over, there is now an extended mandate – certainly in Europe – to monitor and manage any shortages of medicinal products and

  • LifeArc’s challenge to combat bronchiectasis LifeArc’s challenge to combat bronchiectasis

    LifeArc is partnering with the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) to improve healthcare for thousands of people across Europe living with bronchiectasis.

  • The state of pharma customer experience The state of pharma customer experience

    Notably, companies in China – at the time of our research still deep in a strict lockdown – provided HCPs with a customer experience that was on a par with Europe’s two ... However, when we isolate the group of North America and Europe’s five

  • Preparing for a new era in Alzheimer’s disease Preparing for a new era in Alzheimer’s disease

    However, more than 100 drugs designed to slow disease progression are currently being tested in clinical trials and the first such treatment could potentially receive market authorisation in Europe in the

  • A new age of innovation in healthcare A new age of innovation in healthcare

    The economic situation globally, and in Europe specifically, is impacting healthcare and we need to ensure that through diagnosis and treatment, whether that is by digital advances or not, we are ... Although lifespan in Europe is increasing, so too are

More from intelligence
Approximately 20 fully matching, plus 446 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 302 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 338 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...